InsiderTrades

Form 4 for EW Edwards Lifesciences

Accepted 2024-06-20 00:00:00 ET · period of report 2024-06-20 · accession 0001225208-24-006925 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-06-20 2024-06-20 EW Ullem Scott B. CFO, CVP M - OptEx $45.28 +5,625 36.2K +18% +$254.7K
DM 2024-06-20 2024-06-20 EW Ullem Scott B. CFO, CVP S - Sale+OE $87.52 -5,625 30.6K -16% -$492.3K
D 2024-06-20 2024-06-20 EW Ullem Scott B. CFO, CVP M - OptEx $0.00 -5,625 56.2K -9% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-06-20 M A 5,625 $45.28 36,186 D — —
2 Common Common Stock 2024-06-20 S D 400 $88.11 35,786 D — — (F2) This transaction was executed in multiple trades at prices ranging from $88.110 to $88.115. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
3 Common Common Stock 2024-06-20 S D 5,225 $87.47 30,561 D — — (F3) This transaction was executed in multiple trades at prices ranging from $87.065 to $87.860. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
4 Derivative Employee Stock Option (Right to Acquire) 2024-06-20 M D 5,625 $0.00 56,250 D $45.28 · 2019-05-17 to 2025-05-16 5,625 Common Stock